Gastric outlet obstruction (GOO) is a common complication of luminal malignancies which is associated with substantial morbidity. Palliation of GOO has traditionally been through the surgical bypass of the obstructed lumen by creating an opening between the stomach and small intestine. However, In recent years, a less invasive approach, i.e. endoscopic stenting, has gained wide acceptance to treat unresectable malignant gastric outlet obstruction. In this study, the investigators are going to compare the safety and efficacy of the two different endoscopic techniques including Endoscopic ultrasonography-guided gastroenterostomy (EUS-GE) and enteral stenting (ES).
In recent years, Enteral Stenting (ES) has commonly been used as the first line management of unresectable malignant gastric outlet obstruction. On the other hand, Endoscopic ultrasonography-guided gastroenterostomy (EUS-GE) is the most recently described technique for palliation of malignant GOO, which has the theoretical potential to minimize the risk for stent occlusion while maintaining the less invasive endoscopic approach. This novel endoscopic treatment entails creating a gastroenterostomy under EUS-guidance thereby bypassing the occluded lumen. This endoscopic technique has been performed to treat patients with GOO since 2014, and recent retrospective studies have shown that EUS-GE was comparable to ES in terms of efficacy and safety; however, EUS-GE was associated with a significantly decreased risk of recurrent GOO and reinterventions. Based on the investigator's clinical experience for the last three years and the above-mentioned study results, the goal of this study is to prospectively compare EUS-GE with ES in the management of unresectable malignant gastric outlet obstruction. The investigators hypothesize that EUS-GE is associated with comparable technical and clinical success and safety profile while requiring fewer re-interventions.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
112
In this technique, the gastric wall and its adjacent small intestine are punctured by a needle to make a connection between the stomach and small intestine. Then a lumen-apposing metal stent is deployed at the puncture site to keep the stomach-small intestine connection open.
In this technique, under endoscopic visualization, a guidewire will be advanced through the obstructed part of the stomach. Then an enteral self-expandable metal stent will be deployed under direct endoscopic visualization and fluoroscopic guidance.
Yale University
New Haven, Connecticut, United States
The Johns Hopkins Hospital
Baltimore, Maryland, United States
Wake Forest Baptist University
Winston-Salem, North Carolina, United States
The Research Institute of McGill University Health Centre
Montreal, Quebec, Canada
Ecuadorian Institute of Digestive Diseases (IECED)
Guayaquil, Ecuador
Hospital Prive des Peupliers
Paris, France
Asian Institute of Gastroenterology
Hyderabad, India
Emek Medical Center
Afula, Israel
Hospital Universitario Rio Hortega
Valladolid, Spain
Rate of gastric outlet obstruction recurrence
Recurrence of nausea, vomiting, and inability to tolerate PO intake up to 3 months after the procedure confirmed either endoscopically and/or radiographically.
Time frame: 3 months
Technical success rate
Adequate positioning and deployment of the stent(s) as determined endoscopically and radiographically.
Time frame: Day of procedure
Clinical success rate
The improvement of at least 1 point in the gastric outlet obstruction score within 7 days after stent insertion.
Time frame: 1 week
Length of procedure
Time frame: Day of procedure
Adverse events rate
Time frame: 1 week
Post-procedure length of hospital stay
Time frame: 1 week
Reintervention rate for recurrent gastric outlet obstruction
Time frame: 3 months
Quality of Life SF-36 questionnaire scoring
The SF-36 general health questionnaire consists of 36 questions evaluating the patient's perception of their quality of life (QoL) in the following eight subscales: physical functioning (PF), role limitations due to physical problems (RP), role limitations due to emotional problems (RE), energy/fatigue (EF), emotional well-being (EW), social functioning (SF), bodily pain (BP) and general health (GH). Subscale scores range from 0 to 100, with 100 being the best and 0 being the worst quality of life.
Time frame: 3 months
Overall survival rate
Time frame: 1 year
Time to recurrent gastric outlet obstruction
Time frame: 3 months
Gastric Outlet Obstruction Scoring system (GOOSS)
Diet toleration will be scored based on the Gastric Outlet Obstruction Scoring System (GOOSS). The scoring ranges from 0 to 3 in the following format: 0 = no oral intake, 1 = liquids only, 2 = soft solids, 3 = low-residue or full diet
Time frame: 1 year
Stent Dysfunction Rate
the restenosis of the stent due to tumor ingrowth or overgrowth, stent migration, or fracture
Time frame: 3 months
Duration of stent patency
Calculated from the time of stent placement to the time of stent dysfunction
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.